Clinical specimens of non-small cell lung cancer revealed that the overexpression of PFDN1, PFDN3, and PFDN5 are significantly associated with higher mortality and metastasis in non-small cell lung cancer (Peñate et al., 2020). This evidence concerns the gene PFDN5 and non-small cell lung carcinoma.